Yesterday, the FDA issued a notice for the urgent recall of Medtronic's reinforced tracheal tubes, requesting healthcare institutions to stop using the product. This was due to reports that these tubes may experience airflow blockage. This warning applies to the NIM Contact EMG Enhanced Tracheal Tube and the NIM (Standard) EMG Enhanced Tracheal Tube. These products are primarily used in surgical procedures to provide airway ventilation for patients and allow real-time monitoring of EMG activity in the laryngeal cricothyroid muscle and nerve function status, ensuring nerve integrity during surgery.
Multiple complaints received, urgent recall
Medtronic issued an urgent medical device recall notice for catheters on July 9, recalling all models and batches of the product.NIM StandardAndNIM Contact EMGEnhanced tracheal intubation, the company also announced it would cancel all existing orders.
According to the official notice released by Medtronic, from March 2020 to May 2024, the company has cumulatively received77 casesFailure Complaint. The complaint reflects that a large number of tracheal tubes of different models have experienced functional degradation or even complete failure, which may pose a significant threat to patients' health. Potential medical risks include but are not limited to airway obstruction, accidental extubation, bronchospasm, insufficient ventilation, low oxygen saturation, hypoxia, dyspnea, abnormal blood gas analysis, cyanosis, apnea, respiratory arrest, cardiac arrest, brain injury, and even death.(Image captured from the official website)Medtronic advises customers to immediately clear and stop using the affected products in inventory. Users should return the problematic products to the company and report any device-related adverse events to the FDA.Prior to this, Medtronic had already issued a safety alert in April 2022 for this device, specifically reminding users to avoid over-inflating the endotracheal cuff. Subsequently, the FDA implemented a Class I recall of the device in September of the same year, involving nearly400,000 devicesThe recycling campaign.In January this year, Medtronic released FDA-approved label updates and additional supplier notifications, and launched a new anesthesia training program aimed at enhancing the proficiency and safety of healthcare professionals in device usage.
Another Serious Recall Results in 3 Injuries
It was reported that on the 12th of last month, Medline also recalled its tracheal intubation. The recalled product is the Sub-G tracheal tube with subglottic suctioning device it produced. The FDA classified this recall asClass I, the most severe type. The reason for the recall is that the inflation tube and other device components may detach or tear from the main tube. This could lead to cuff leakage, deflation, moisture accumulation, and inflation failure. Moreover, if the device detaches during use, partial or complete airway obstruction and suffocation may occur.
This recall, which began in February this year, includes the removal of devices from places where they were used or sold. It covers six Sub-G endotracheal tubes with subglottic suction and ten kits containing these devices. Customers in possession of the kits should immediately check their inventory and destroy any affected stock.According to the FDA notification, Medline also received reports about the difficulty in tearing the package. Users also reported that the suction port is hard to connect and may fall off during use. The FDA reported that the recalled devices have caused three injuries and no deaths.Tracheal Intubation Market: The Lifeline of Respiration
Tracheal intubation, as a key medical device to ensure unobstructed airways in patients, plays an irreplaceable role in surgical procedures, emergency treatment, intensive care, and specific diagnostic processes. With the continuous expansion and improvement of global medical infrastructure, coupled with the aging population trend and the rising incidence of chronic diseases, the market demand for tracheal intubation is showing steady growth.
According to the latest market research report, the global tracheal intubation market size reachedRMB 4.062 billion, and it is expected that by 2028, this figure will climb toRMB 5.236 billion，The compound annual growth rate during this period is approximately 4.31%.. In the global tracheal intubation market landscape,Medtronic, Johnson & Johnson, Beckman CoulterMultinational corporations such as Medtronic, Medline Industries, Inc. dominate.In the Chinese market, the tracheal intubation industry also shows a vigorous development momentum.Medtronic, Teleflex Medical, Smiths Medical, Cardinal Health, FreseniusInternational brands such as Medtronic and Medline are leading market trends, while domestic companies in China, likeHenan Tuoren, Shandong Weigao, Well Lead MedicalAlso emerging in the domestic market, the combined market share of the top three companies accounts for approximately 40%-50%.To reduce potential airway injury and other complications during tracheal intubation and use, leading manufacturers in the industry are actively investing in innovative designs. For instance, the flexible tracheal tube (Parker flex-tip ETT) introduced by WeiLi Medical features a tip made of soft and highly elastic material, effectively minimizing mechanical damage to airway tissues and significantly enhancing patient safety and comfort.Every recall represents a profound reflection on the safety standards of medical devices, offering valuable opportunities for future device improvements. It serves as both a test of corporate responsibility and an evaluation of the effectiveness of the regulatory system. Ensuring the safety and efficacy of medical devices requires the joint efforts of companies, regulatory agencies, and the entire industry.In response to the recall incidents, the entire industry should be highly vigilant and focus on enhancing the safety standards of medical devices to ensure that every patient receives the safest and most effective treatment. As emphasized by the U.S. Food and Drug Administration (FDA), recalls are a necessary part of the medical device lifecycle management, aimed at protecting public health. We look forward to seeing more proactive measures that will collectively drive continuous improvement and advancement in the healthcare industry.▲Source: Medical Device Innovation Network▲Reproduction without permission is prohibited.And can be reprinted after 24 hours！Disclaimer: This article is for informational purposes only and serves as a reference. It does not constitute any advice on investment or treatment. Please exercise caution and discretion. If there are any issues related to the content, copyright, or other aspects of the work, to ensure the rights and interests of both parties, please contact us, and we will handle it immediately.. If any platform reprints this article, it shall be responsible for the content of the article itself. The Medical Device Innovation Network will not be responsible for any secondary dissemination caused by the reprint.
